Article Details

Zacks Investment Research Downgrades Phathom Pharmaceuticals (NASDAQ:PHAT) to Sell

Retrieved on: 2021-04-03 04:52:30

Tags for this article:

Click the tags to see associated articles and topics

Zacks Investment Research Downgrades Phathom Pharmaceuticals (NASDAQ:PHAT) to Sell. View article details on hiswai:

Excerpt

Phathom Pharmaceuticals (NASDAQ:PHAT) was downgraded by Zacks Investment Research from a "hold" rating to a "sell" rating in a research note ...

Article found on: www.marketbeat.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up